Interventional Pain Medicine最新文献

Corrigendum to “Genicular nerve block with corticosteroid for chronic knee Pain: Patient-Reported outcomes across 9-years of practice” [Intervent Pain Med 4 (2025) 100601] “膝神经阻滞与皮质类固醇治疗慢性膝关节疼痛：患者报告的9年实践结果”的勘误表[介入疼痛医学4 (2025)100601]

Interventional Pain Medicine Pub Date : 2025-06-25 DOI: 10.1016/j.inpm.2025.100602

Mingda Chen , Sercan Tosun , Nicolas R. Thompson , Kush K. Goyal

引用次数: 0

Letter to the editor: Challenging epidural catheterization in a patient with vertebral metastases 致编辑：对椎骨转移患者硬膜外置管的挑战

Interventional Pain Medicine Pub Date : 2025-06-24 DOI: 10.1016/j.inpm.2025.100603

Nurbanu Hindioglu Dogan, Serdar Kokar, Savas Sencan, Osman Hakan Gunduz

引用次数: 0

Mastering the GON Block: A practical four-step ultrasound-Guided approach 掌握GON块：一个实用的四步超声引导方法

Interventional Pain Medicine Pub Date : 2025-06-24 DOI: 10.1016/j.inpm.2025.100605

Mustafa Turgut Yildizgoren , Hatice Ozeken , Abdulkadir Bartu , Fatih Bagcier

引用次数: 0

Spinal cord stimulation for Tarlov cyst-related pain: Initial success and subsequent explantation in an elderly patient 脊髓刺激治疗塔洛夫囊肿相关疼痛：一位老年患者的初步成功和随后的移植

Interventional Pain Medicine Pub Date : 2025-06-21 DOI: 10.1016/j.inpm.2025.100604

Alexandre J. Bourcier MD, MSc , Christina Im BA , Jane Phan BA , Michelle Nwufo MSc , Miad Hadaegh MD , Colton M. Malesovas MD , Jae Jung MD , Kyle Yang MD , Jonathan Droessler MD

引用次数: 0

What is the optimal block selection paradigm for predicting a successful treatment outcome following sacral lateral branch radiofrequency neurotomy? A real-world cohort study 预测骶骨外侧支射频神经切开术后成功治疗结果的最佳阻滞选择范例是什么？一个真实世界的队列研究

Interventional Pain Medicine Pub Date : 2025-06-01 DOI: 10.1016/j.inpm.2025.100599

Katharine A. Smolinski , Christopher Radlicz , Hasan Sen , Amanda N. Cooper , Brook Martin , Alycia Amatto , Allison Glinka Przybysz , Robert Burnham , Aaron M. Conger , Zachary L. McCormick , Taylor R. Burnham

{"title":"What is the optimal block selection paradigm for predicting a successful treatment outcome following sacral lateral branch radiofrequency neurotomy? A real-world cohort study","authors":"Katharine A. Smolinski , Christopher Radlicz , Hasan Sen , Amanda N. Cooper , Brook Martin , Alycia Amatto , Allison Glinka Przybysz , Robert Burnham , Aaron M. Conger , Zachary L. McCormick , Taylor R. Burnham","doi":"10.1016/j.inpm.2025.100599","DOIUrl":"10.1016/j.inpm.2025.100599","url":null,"abstract":"<div><h3>Background</h3><div>Outcomes following sacral lateral branch radiofrequency neurotomy (SLBRFN) likely depend on patient selection criteria; however, commonly used criteria vary considerably. Refinement of selection criteria for SLBRFN may improve treatment outcomes. This study investigated common prognostic block-based selection criteria and treatment success following SLBRFN.</div></div><div><h3>Methods</h3><div>In this retrospective cohort study, consecutive patients from two Canadian musculoskeletal pain management clinics who underwent SLBRFN over a 6-year period (2016–2022) were identified by electronic medical record. Patients were categorized according to several prognostic block paradigms based on number of blocks (single vs. dual), block type (lateral branch block [LBB] vs. intra-articular block [IAB]), and subsequent percentage of pain relief. Six block criteria were established: 1 = LBB/LBB≥80 %; 2 = IAB/LBB≥80 %; 3 = LBB/LBB 50–79 %; 4 = IAB/LBB 50–79 %; 5 = LBB≥80 %; 6 = LBB 50–79 %. Treatment success was assessed at three months post-SLBRFN using two criteria: (1) the primary study outcome of ≥50 % numerical rating scale (NRS) pain reduction and (2) a secondary outcome of Pain Disability Quality-of-Life Questionnaire (PDQQ) score improvement by the minimal clinically important difference (MCID). Logistic regression analyses evaluated the association between block criteria and treatment success following SLBRFN.</div></div><div><h3>Results</h3><div>281 consecutive patients (75.1 % female, 61.8 ± 14.2 years of age, BMI 29.4 ± 6.6 kg/m<sup>2</sup>) were included. Cohort success rates for pain and functional improvement were 43.4 % (95 % CI: 37.8–49.3) and 46.6 % (95 % CI: 40.9–52.5), respectively. After adjusting for demographics and cannula type/SLBRFN technique, none of the odds ratios for the six prognostic block paradigms showed statistical significance.</div></div><div><h3>Conclusion</h3><div>Nearly 50 % of patients who underwent SLBRFN reported clinically significant improvement in pain and disability at three months post-procedure, regardless of prognostic block selection criteria. These results suggest that multiple block strategies may determine eligibility for SLBRFN.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"4 2","pages":"Article 100599"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144189478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Genicular nerve block with corticosteroid for chronic knee Pain: Patient-Reported outcomes across 9-years of practice 膝神经阻滞与皮质类固醇治疗慢性膝关节疼痛：患者报告的结果跨越9年的实践

Interventional Pain Medicine Pub Date : 2025-06-01 DOI: 10.1016/j.inpm.2025.100601

Mingda Chen , Sercan Tosun , Nicolas R. Thompson , Kush K. Goyal

{"title":"Genicular nerve block with corticosteroid for chronic knee Pain: Patient-Reported outcomes across 9-years of practice","authors":"Mingda Chen , Sercan Tosun , Nicolas R. Thompson , Kush K. Goyal","doi":"10.1016/j.inpm.2025.100601","DOIUrl":"10.1016/j.inpm.2025.100601","url":null,"abstract":"<div><h3>Background</h3><div>Genicular nerve blocks (GNB) for knee pain secondary to osteoarthritis (OA) are often performed with an anesthetic only, but corticosteroid can be used as an adjuvant with the goal of extending therapeutic relief. The efficacy of GNB with corticosteroid has been established in small, randomized trials, but its effectiveness in practice remains largely unknown.</div></div><div><h3>Objectives</h3><div>Evaluate the therapeutic effect of GNB with corticosteroid using patient-reported outcomes (PROs) in a large patient sample.</div></div><div><h3>Methods</h3><div>Data from consecutive GNBs with corticosteroid performed at an academic medical center from 2015 to 2024 was collected retrospectively. We included all patients aged ≥18 who received a GNB with corticosteroid for chronic knee pain due to OA, and excluded diagnostic GNBs with anesthetic alone and procedures performed using non-classical/modified techniques. Comparisons between pre-versus post-procedure PROs were by mixed-effect regression models with multiple testing corrections.</div></div><div><h3>Results</h3><div>A total of 123 GNBs (96 patients) with corticosteroid were identified. Post-procedurally, the mean NRS reductions were 3.56 (2–30 days), 2.14 (1–3 months), 1.92 (3–6 months), and 1.23 (6–12 months). 50 % of the patients maintained a pain reduction greater than or equal to the NRS MCID of −2.0 for at least 6.9 months. Post-procedure improvements in PROMIS-GH and PHQ9 were not clinically significant. Mean time to total knee arthroplasty was 16.5 months in 13.5 % of patients (13/96). For active opioid users, opioid usage was significantly decreased from the baseline 28.01 ± 13.20 MME/day to 13.58 ± 16.23 MME/day (p < 0.002) in the first 6 months post-GNB, and this opioid reduction was maintained at 15.59 ± 12.51 MME/day (p < 0.05) after the initial 6-month follow-up period.</div></div><div><h3>Conclusion</h3><div>For the majority of patients who received GNB with corticosteroid, we observed statistically and clinically significant pain reduction for 3 months or more in this cohort. While more comparative studies are required to evaluate its effectiveness, GNB with corticosteroid has promising potential as a safe and effective treatment for chronic knee pain.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"4 2","pages":"Article 100601"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144184645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Postamputation pain treatment by radiofrequency ablation of common peroneal nerve 腓总神经射频消融术治疗截肢后疼痛

Interventional Pain Medicine Pub Date : 2025-06-01 DOI: 10.1016/j.inpm.2025.100600

David Majure , Mark Shilling , Janssen Puracan , Eugene Koshkin , Reza Ehsanian

引用次数: 0

Transsacrococcygeal ganglion impar block 经acrococcgal单侧淋巴结阻滞

Interventional Pain Medicine Pub Date : 2025-06-01 DOI: 10.1016/j.inpm.2025.100595

Kelly Li , David Hao

引用次数: 0

Perspectives on treatment decision-making across racial groups in adults with degenerative lumbar disease – A pilot study 不同种族对成人退行性腰椎疾病治疗决策的看法——一项初步研究

Interventional Pain Medicine Pub Date : 2025-06-01 DOI: 10.1016/j.inpm.2025.100596

Emmy Duerr , Emily Rodriguez , Meron Nephtalem , Emmanuel Mensah , John R. Duffy , Thomas Cha , Jessica Aidlen , Chadi Tannoury , Michael D. Perloff , Keren Ladin , David Hao , Theresa Williamson

{"title":"Perspectives on treatment decision-making across racial groups in adults with degenerative lumbar disease – A pilot study","authors":"Emmy Duerr , Emily Rodriguez , Meron Nephtalem , Emmanuel Mensah , John R. Duffy , Thomas Cha , Jessica Aidlen , Chadi Tannoury , Michael D. Perloff , Keren Ladin , David Hao , Theresa Williamson","doi":"10.1016/j.inpm.2025.100596","DOIUrl":"10.1016/j.inpm.2025.100596","url":null,"abstract":"<div><h3>Introduction</h3><div>Degenerative lumbar spine disease significantly impairs quality of life, yet racial and socioeconomic disparities in surgical treatment persist, particularly among BIPOC (Black, Indigenous, and Persons of Color) patients, who often experience worse outcomes and are less likely to undergo surgery despite similar or higher pain levels.</div></div><div><h3>Objectives</h3><div>This study explored factors that influence treatment decisions among BIPOC and Non-Hispanic White (NHW) patients with degenerative lumbar spine disease, with a focus on understanding how these factors may contribute to disparities in surgical care utilization.</div></div><div><h3>Methods</h3><div>An explorative qualitative study was conducted using semi-structured interviews with 20 patients (10 BIPOC, 10 NHW) considering lumbar spine surgery for spinal stenosis or disc herniation at three major academic institutions in Massachusetts. Thematic analysis identified key themes related to emotional suffering, financial concerns, support systems, and familiarity with spine surgery.</div></div><div><h3>Results</h3><div>BIPOC patients expressed greater anxiety about surgery, often shaped by prior negative healthcare experiences and broader systemic mistrust. Financial and occupational concerns were more significant for BIPOC patients, who frequently prioritized employment over symptom relief. In contrast, NHW patients more often cited quality-of-life goals as their primary motivator. While perception of support systems were comparable between the groups, emotional suffering was universally reported emotional suffering, with participants using terms such as “miserable,” “scared,” “embarrassed,” and “ashamed.”</div></div><div><h3>Conclusion</h3><div>Emotional, financial, and trust-related differences shape surgical decision-making among racially and ethnically diverse patients with lumbar spine disease. Incorporating culturally responsive communication strategies and decision aids that address patients fears, values, and social contexts may enhance shared decision-making and promote more equitable access to spine surgery.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"4 2","pages":"Article 100596"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144204894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Biochemical reactions and ultrasound insights in percutaneous needle electrolysis therapy 经皮针电解治疗的生化反应及超声观察

Interventional Pain Medicine Pub Date : 2025-06-01 DOI: 10.1016/j.inpm.2025.100593

Mustafa Turgut Yildizgoren , Sema Nur Mutlu Ekici , Burak Ekici

引用次数: 0